Golden Valley Development, Inc (GVDI)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | 47.65 Million USD | 549.96% |
| 2014 | 7.33 Million USD | -93.88% |
| 2013 | 119.81 Million USD | 0.0% |
| 2011 | 170.33 Thousand USD | -15.68% |
| 2010 | 201.99 Thousand USD | 129.53% |
| 2009 | 88 Thousand USD | 46.54% |
| 2008 | 60.05 Thousand USD | 16.97% |
| 2007 | 51.34 Thousand USD | -53.33% |
| 2006 | 110 Thousand USD | 107.07% |
| 2005 | 53.12 Thousand USD | 1.36% |
| 2004 | 52.41 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2016 Q1 | 8.62 Million USD | -81.91% |
| 2015 Q2 | 7.84 Million USD | 7.64% |
| 2015 Q3 | 64.17 Million USD | 717.59% |
| 2015 Q4 | 47.65 Million USD | -25.74% |
| 2015 FY | 47.65 Million USD | 549.96% |
| 2015 Q1 | 7.29 Million USD | -0.54% |
| 2014 Q4 | 7.33 Million USD | 0.0% |
| 2014 FY | 7.33 Million USD | -93.88% |
| 2013 FY | 119.81 Million USD | 0.0% |
| 2011 FY | 170.33 Thousand USD | -15.68% |
| 2010 Q2 | 96.59 Thousand USD | 6.59% |
| 2010 FY | 201.99 Thousand USD | 129.53% |
| 2010 Q1 | 90.62 Thousand USD | 2.97% |
| 2009 Q1 | 74.82 Thousand USD | 24.59% |
| 2009 FY | 88 Thousand USD | 46.54% |
| 2009 Q4 | 88 Thousand USD | 12.09% |
| 2009 Q2 | 72.69 Thousand USD | -2.84% |
| 2009 Q3 | 78.51 Thousand USD | 8.0% |
| 2008 Q1 | 53.38 Thousand USD | 3.99% |
| 2008 Q4 | 60.05 Thousand USD | 0.95% |
| 2008 Q3 | 59.48 Thousand USD | 6.98% |
| 2008 Q2 | 55.6 Thousand USD | 4.15% |
| 2008 FY | 60.05 Thousand USD | 16.97% |
| 2007 Q3 | 50.71 Thousand USD | -76.61% |
| 2007 Q2 | 216.8 Thousand USD | 204.41% |
| 2007 Q4 | 51.34 Thousand USD | 1.24% |
| 2007 FY | 51.34 Thousand USD | -53.33% |
| 2007 Q1 | 71.22 Thousand USD | -35.25% |
| 2006 Q3 | 100 Thousand USD | 88.25% |
| 2006 Q2 | 53.12 Thousand USD | -35.22% |
| 2006 Q1 | 82 Thousand USD | 54.37% |
| 2006 FY | 110 Thousand USD | 107.07% |
| 2006 Q4 | 110 Thousand USD | 10.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | 53.12 Thousand USD | 1.36% |
| 2005 Q3 | 53.79 Thousand USD | 0.0% |
| 2005 Q4 | 53.12 Thousand USD | -1.25% |
| 2004 FY | 52.41 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 100.0% |
| Ansell Limited | 1.32 Billion USD | 100.0% |
| Ansell Limited | 1.33 Billion USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 126.33 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 943.17 Thousand USD | 100.0% |
| Psykey, Inc. | 2.47 Million USD | 100.0% |
| ConvaTec Group Plc | 2.01 Billion USD | 100.0% |
| ConvaTec Group Plc | 2.02 Billion USD | 100.0% |
| Encision Inc. | 1.98 Million USD | 100.0% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 100.0% |
| Innovative MedTech Inc. | 6.13 Million USD | 100.0% |
| LifePoint, Inc. | 2.45 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 3.04 Million USD | 100.0% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 982.26 Million USD | 100.0% |
| Sector 10, Inc. | 9.84 Million USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 100.0% |
| SheerVision, Inc. | 1.43 Million USD | 100.0% |
| United Health Products, Inc. | 1.99 Million USD | 100.0% |
| Vasamed, Inc. | 1 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 100.0% |
| Yubo International Biotech Limited | 2.91 Million USD | 100.0% |